Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Newton

Showing results (31-40 of 474) with videos related to

Pageof 48
Sort By:
Atherosclerosis. Supplements|February 8, 2003
HDL therapy for the acute treatment of atherosclerosisRoger S Newton, Brian R Krause
Plant Molecular Biology|February 24, 2001
An osmotin-like cryoprotective protein from the bittersweet nightshade Solanum dulcamaraS S Newton, J G Duman
Biological Psychiatry|June 19, 2007
Epigenetic marking and neuronal plasticityRonald S Duman, Samuel S Newton
Expert Opinion on Drug Discovery|March 15, 2013
Customizing microarrays for neuroscience drug discoveryMatthew J Girgenti, Samuel S Newton
CJEM|March 7, 2023
Virtual ED mental healthcare: a flash in the pan or the way of the future?Amanda S Newton, Jennifer Thull-Freedman
Journal of Lipid Research|August 1, 1985
Apolipoprotein changes associated with the plasma lipid-regulating activity of gemfibrozil in cholesterol-fed ratsB R Krause, R S Newton
Atherosclerosis|January 1, 1986
Gemfibrozil increases both apo A-I and apo E concentrations. Comparison to other lipid regulators in cholesterol-fed ratsB R Krause, R S Newton
Computers in Hospitals|June 10, 1982
Computerized pharmacy services merely continues century-old tradition at Roper HospitalN S Newton, J W Chisena
American Journal of Public Health|December 1, 2001
A bold new direction for environmental health researchK Olden, J Guthrie, S Newton
Advances and Applications in Bioinformatics and Chemistry : AABC|November 10, 2018
Computational analysis of ligand-receptor interactions in wild-type and mutant erythropoietin complexesNicholas J Pekas, Samuel S Newton
Pageof 48

Showing results (31-40 of 474) with videos related to

Sort By:
Pageof 48
Atherosclerosis. Supplements|February 8, 2003
HDL therapy for the acute treatment of atherosclerosisRoger S Newton, Brian R Krause
Plant Molecular Biology|February 24, 2001
An osmotin-like cryoprotective protein from the bittersweet nightshade Solanum dulcamaraS S Newton, J G Duman
Biological Psychiatry|June 19, 2007
Epigenetic marking and neuronal plasticityRonald S Duman, Samuel S Newton
Expert Opinion on Drug Discovery|March 15, 2013
Customizing microarrays for neuroscience drug discoveryMatthew J Girgenti, Samuel S Newton
CJEM|March 7, 2023
Virtual ED mental healthcare: a flash in the pan or the way of the future?Amanda S Newton, Jennifer Thull-Freedman
Journal of Lipid Research|August 1, 1985
Apolipoprotein changes associated with the plasma lipid-regulating activity of gemfibrozil in cholesterol-fed ratsB R Krause, R S Newton
Atherosclerosis|January 1, 1986
Gemfibrozil increases both apo A-I and apo E concentrations. Comparison to other lipid regulators in cholesterol-fed ratsB R Krause, R S Newton
Computers in Hospitals|June 10, 1982
Computerized pharmacy services merely continues century-old tradition at Roper HospitalN S Newton, J W Chisena
American Journal of Public Health|December 1, 2001
A bold new direction for environmental health researchK Olden, J Guthrie, S Newton
Advances and Applications in Bioinformatics and Chemistry : AABC|November 10, 2018
Computational analysis of ligand-receptor interactions in wild-type and mutant erythropoietin complexesNicholas J Pekas, Samuel S Newton
Pageof 48